From Binary Senescence To State-Resolved Senotherapy In Cancer: Therapeutic Windows From Heterogeneity
Our bodies have a natural defense mechanism called cellular senescence, where cells stop dividing in response to stress, like damage or abnormal growth. While this can prevent cancer by halting the spread of potentially harmful cells, it’s not always straightforward. These “senescent” cells can also release a mix of chemicals, known as the senescence-associated secretory phenotype (SASP), which can paradoxically promote tumor growth, help cancer cells evade the immune system, and even make treatments less effective.
The challenge is that not all senescent cells are the same. Their chemical output and overall behavior can vary significantly depending on the cell type, their location within the tumor, and the stage of treatment. This means that simply trying to eliminate all senescent cells, or just blocking their secretions, might not be the best approach, and could even be harmful in some cases.
To overcome this, researchers are now advocating for a more precise understanding of these diverse senescent cell “states.” By using advanced tools like artificial intelligence, combined with detailed analyses of individual cells and their environment, we can map out these different states. This deeper insight allows us to identify specific “therapeutic windows” – moments and contexts where targeting senescent cells, either by removing them (senolytics) or modifying their harmful secretions (senomorphics), would be most beneficial. This personalized approach promises to unlock new strategies for more effective and tailored cancer treatments.
Source: link to paper